Structural Market Changes Needed to Achieve Cost-Savings from Biosimilars

The Biosimilars Forum and Medicines for Europe released a joint report today exploring how European countries have successfully instituted and sustained a multi-source, competitive biosimilars market over the last decade. The report also lays out a roadmap for United States (U.S.) policymakers to ensure that patients have access to the treatments they need and that the healthcare system at-large achieves the significant potential for cost-savings associated with a vibrant biosimilars market.